Latest Financial Health News

Australis Oil & Gas reported a modest dip in production volumes for Q3 2025 but offset this with higher realised oil prices and disciplined cost management. The company remains focused on securing a development partner to unlock the full potential of its Tuscaloosa Marine Shale assets.

MAAS Group Holdings reported a 6% rise in FY25 underlying EBITDA to $219.4 million, driven by strong construction materials growth and strategic acquisitions. The company projects FY26 EBITDA between $240 million and $270 million, underpinned by renewable energy projects and a robust capital recycling program.

Hazer Group has made significant strides in commercialising its methane pyrolysis technology, advancing key partnerships and strengthening its intellectual property portfolio amid a tightening global graphite market.

Freelancer Limited reported a steady third quarter with operational profitability and notable growth in AI-related projects and Loadshift revenues, despite a year-on-year dip in overall marketplace volume.

Ballard Mining’s September quarter report highlights promising drilling results at its Mt Ida Gold Project and secures final approvals for a 2.0 Mtpa processing plant, underpinning its development ambitions.

Vitrafy Life Sciences has delivered its first production unit of the next-generation cryopreservation device, advanced its US commercial footprint, and maintained a strong financial position heading into FY2026.

Weebit Nano has reported a record quarter with A$7.3 million in customer receipts, securing three key product agreements and progressing critical technology milestones at leading semiconductor fabs.

PolyNovo Limited reported a robust 33.3% increase in Q1 FY26 sales, driven by strong U.S. growth and a remarkable surge in NovoSorb MTX sales. The company also completed key infrastructure projects, positioning itself for further expansion.

DroneShield Limited has delivered a blockbuster quarter with record revenue and operating cash flow, driven by new SaaS products and major government contracts. The company is positioning itself for sustained profitability and expansion into civilian markets.

DGL Group Limited remains suspended from ASX trading following delays in lodging audited accounts and a concerning auditor disclaimer. Investors await clarity on the company’s financial health and path to reinstatement.

AVITA Medical has appointed Board Chairman Cary Vance as Interim CEO following Jim Corbett's departure, while preliminary third-quarter revenue is expected to reach approximately $17 million.

Fiducian Group Limited has voluntarily released its Appendix 4C for Q3 2025, reporting steady net inflows to its core platform and a rise in total funds under management to $15.6 billion.